Phylogenetic Characteristics of HIV-1 Among Travelers Entering China from Myanmar: A Retrospective Study
Overview
Authors
Affiliations
Due to the open policy of the Chinese government, a large number of Burmese individuals enter China at land ports in Yunnan province for travel or business. However, the situation of HIV-1 infection and its phylogenetic characteristics among these travelers remains unclear, which is a potential threat to public health. From January 2003 to December 2012, a total of 1,961 travelers were detected to be positive for HIV-1 infection at land ports between Myanmar and Yunnan province, China. From 1153 (58.8%) Burmese of them, we randomly collected 489 serum samples for HIV-1 subtype/recombinant analysis. Based on successfully obtained 223 gag-RT sequences, 187 of them were genotyped as 2 subtypes and 3 CRFs. CRF01_AE was showed to be the most prevalent genotype (54.3%), followed by subtypes C (13.5%) and B (10.8%). Notably, CRF07_BC (1.3%) and CRF08_BC (4.0%) were mainly distributed in travelers from Shan state and Kachin (91.7%, 11/12), but was not found in travelers from the capital city of Yangon (0/16). Additionally, there were 36 samples (16.1%) were preliminary determined as unique recombinant forms (URFs). The higher HIV-1 infection among entering travelers from Myanmar and its diverse and complex genotypes distribution suggest this bridge population may facilitate the transmission of HIV-1. It is necessary to have the strict monitoring on this population for prevention of HIV-1 cross-border transmission.
Liu H, Jin Y, Yang Y, Duan X, Cao Y, Shan D Emerg Microbes Infect. 2024; 13(1):2409319.
PMID: 39315943 PMC: 11443545. DOI: 10.1080/22221751.2024.2409319.
HIV-1 env gene mutations outside the targeting probe affects IPDA efficiency.
Zhou Z, Zhang X, Wang M, Jiang F, Tong J, Nie J iScience. 2024; 27(6):109941.
PMID: 38812543 PMC: 11133923. DOI: 10.1016/j.isci.2024.109941.
Hu Z, Liu Y, Wang J, Meng Z, Leuba S, Wei J Front Med (Lausanne). 2022; 8:693915.
PMID: 35572804 PMC: 9094042. DOI: 10.3389/fmed.2021.693915.
Guo P, He H, Chen X, Chen J, Chen X, Lan Y Front Pharmacol. 2021; 11:569766.
PMID: 33841131 PMC: 8027496. DOI: 10.3389/fphar.2020.569766.
Chen X, Zhou Y, Ye M, Wang Y, Duo L, Pang W Virulence. 2018; 9(1):1195-1204.
PMID: 30001176 PMC: 6086311. DOI: 10.1080/21505594.2018.1496777.